CDK9 and breast cancer: miR-874 contributes to inhibit tumor angiogenesis through targeting STAT3 in gastric cancer [43], which can also inhibit cell proliferation and induce apoptosis in human breast cancer by targeting cyclin-dependent kinase 9 (CDK9) [44].